Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

rocherooflr

FDA awards Roche priority review in HER2-positive breast cancer

October 2, 2017
Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical

Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …

News
shutterstock_138095450

CureTech reclaims rare disease drug from Pfizer for $20 million

October 2, 2017
Sales and Marketing Clal Biotechnology, CureTech, Medivation, Pfizer, pharma, pharmaceutical

CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …

News
ablynx_building_web

Ablynx posts strong data on key drug, looks set for approval

October 2, 2017
Research and Development, Sales and Marketing Ablynx, biotech, drugs, pharma, pharmaceutical

In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary …

News
lilly_logo_2

Lilly reveals major senior leadership reshuffle

October 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly revealed on 29 September that it would promote four staff members to senior staff positions, and two senior …

Appointment
merck_incweb

MSD pulls out of hep C space to Gilead’s relief

October 2, 2017
Sales and Marketing MSD, biotech, drugs, hepatitis C, pharma, pharmaceutical

MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in …

News
gilead_senior_management

Gilead’s COO retires, shares take a dive

September 29, 2017
Medical Communications Gilead, Kevin Young, biotech, drugs, pharma, pharmaceutical

Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. …

News
fda2outsideweb

Makers of immediate-release opioids must fund training on their use, FDA says

September 29, 2017
Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin

As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …

News
lilly2_web

Lilly receives FDA breast cancer pill approval, doubts remain

September 29, 2017
Medical Communications, Sales and Marketing Eli Lilly, Verzenio, biotech, drugs, pharma, pharmaceutical

Eli Lilly has received an important approval for its breast cancer treatment, Verzenio. The drug will be the third to …

News
humira_abbott_

Five more biosimilar-free years for AbbVie’s megablockbuster

September 28, 2017
Medical Communications, Sales and Marketing AbbVie, Amgen, Amjevita, Humira, biotech, drugs, pharma, pharmaceutical

Humira is the key drug for AbbVie, and one the company hopes it will be able to push into the …

News
hassan_fahmi

Novo Nordisk Egypt promotes new General Manager

September 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, biotech, drugs, pharma, pharmaceutical

Novo Nordisk Egypt has promoted Hassan Fahmi to become its new General Manager for operations within the company. Fahmi arrived …

Appointment
hiv_test

Rates of HIV rise amongst older population

September 28, 2017
Medical Communications HIV, HIV test, biotech, drugs, pharma, pharmaceutical

It is rare to hear bad news in the fight against the spread of HIV, with the global campaign against …

News
shutterstock_114306559

Could the new EU Medical Devices Regulation put the UK MedTech industry in peril?

September 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medical devices, medical technology, medtech, medtech regulation, pharma, pharmaceutical

Gill Jennings and Every’s Fiona Stevens discusses recent developments in medical devices regulation and the subsequent impact on IP and …

Feature
roche

Roche chalks up Swiss approval for multiple sclerosis drug Ocrevus

September 28, 2017
Sales and Marketing Ocrevus, Roche, multiple sclerosis, pharma, pharmaceutical

Roche has announced that its drug Ocrevus (ocrelizumab) has received marketing approval in Switzerland for the treatment of active relapsing …

News
sanofi_regeneron

Sanofi and Regeneron’s projected blockbuster gains EU approval

September 28, 2017
Sales and Marketing Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …

News
shutterstock_95714119

29% of breast cancer trials do not establish control arm, study says

September 28, 2017
Research and Development clinical trials, pharma, pharmaceutical

As part of the effort to conduct ethical and scientifically safe, effective clinical trials, the standard for researchers carrying out …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026